Methylene blue induced methemoglobinemia with acute kidney injury in a glucose-6-phosphate dehydrogenase-deficient patient
Autor: | Manish R Balwani, Yadav R, Charulata Bawankule, Vakil S, Priyanka Tolani, Ramteke |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
methemoglobinemia
medicine.medical_treatment Case Report Pharmacology Methemoglobinemia lcsh:RC870-923 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine nitrobenzene poisoning hemic and lymphatic diseases medicine Glucose-6-phosphate dehydrogenase 030212 general & internal medicine Antidote Dialysis business.industry Acute kidney injury medicine.disease Ascorbic acid lcsh:Diseases of the genitourinary system. Urology chemistry glucose-6-phosphate dehydrogenase deficiency Nephrology methylene blue business 030217 neurology & neurosurgery Methylene blue Glucose-6-phosphate dehydrogenase deficiency |
Zdroj: | Indian Journal of Nephrology, Vol 27, Iss 6, Pp 465-467 (2017) Indian Journal of Nephrology |
ISSN: | 1998-3662 0971-4065 |
Popis: | Our case was treated with methylene blue for symptomatic nitrobenzene poisoning. After which he developed methemoglobinemia with acute kidney injury due to hemolysis and on further testing, he was found to be glucose-6-phosphate dehydrogenase (G6PD) enzyme deficient. Thus, afterward, the patient was treated with only available mode of treatment as repeated blood transfusions and ascorbic acid with dialysis support to which the patient responded. Thus, it is important to evaluate for the G6PD deficiency where methylene blue treatment is planned as an antidote to nitrobenzene compounds poisoning. |
Databáze: | OpenAIRE |
Externí odkaz: |